Ranad Shaheen1, Amal Al Hashem2, Mohammed H Alghamdi3, Mohammed Zain Seidahmad4, Salma M Wakil1, Khalid Dagriri5, Bernard Keavney6, Judith Goodship7, Saad Alyousif4, Fahad M Al-Habshan8, Khalid Alhussein4, Agaadir Almoisheer1, Niema Ibrahim1, Fowzan S Alkuraya9. 1. Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. 2. Department of Pediatrics, Prince Sultan Military Medical City, Riyadh, Saudi Arabia Department of Anatomy and Cell Biology, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia. 3. Department of Cardiac Sciences, College of Medicine, King Saud University, Riyadh, Saudi Arabia. 4. Department of Pediatrics, Security Forces Hospital, Riyadh, Saudi Arabia. 5. Department of Pediatric Cardiology, Prince Sultan Cardiac Center, Riyadh, Saudi Arabia. 6. Institute of Cardiovascular Sciences, University of Manchester, Manchester, UK. 7. Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK. 8. Department of Cardiology, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. 9. Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia Department of Anatomy and Cell Biology, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Abstract
BACKGROUND: Truncus arteriosus (TA) is characterised by failure of septation of the outflow tract into aortic and pulmonary trunks and is associated with high morbidity and mortality. Although ranked among the least common congenital heart defects, TA provides an excellent model for the role of individual genes in cardiac morphogenesis as exemplified by TBX1 deficiency caused by point mutations or, more commonly, hemizygosity as part of the 22q11.2 deletion syndrome. The latter genetic lesion, however, is only observed in a proportion of patients with TA, which suggests the presence of additional disease genes. OBJECTIVE: To identify novel genes that cause Mendelian forms of TA. METHODS AND RESULTS: We exploited the occurrence of monogenic forms of TA in the Saudi population, which is characterised by high consanguinity, a feature conducive to the occurrence of Mendelian phenocopies of complex phenotypes as we and others have shown. Indeed, we demonstrate in two multiplex consanguineous families that we are able to map TA to regions of autozygosity in which whole-exome sequencing revealed homozygous truncating mutations in PRKD1 (encoding a kinase derepressor of MAF2) and NRP1 (encoding a coreceptor of vascular endothelial growth factor (VEGFA)). Previous work has demonstrated that Prkd1(-/-) is embryonic lethal and that its tissue-specific deletion results in abnormal heart remodelling, whereas Nrp1(-/-) develops TA. Surprisingly, molecular karyotyping to exclude 22q11.2 deletion syndrome in the replication cohort of 17 simplex TA cases revealed a de novo hemizygous deletion that encompasses PRDM1, deficiency of which also results in TA phenotype in mouse. CONCLUSIONS: Our results expand the repertoire of molecular lesions in chromatin remodelling and transcription factors that are implicated in the pathogenesis of congenital heart disease in humans and attest to the power of monogenic forms of congenital heart diseases as a complementary approach to dissect the genetics of these complex phenotypes. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
BACKGROUND:Truncus arteriosus (TA) is characterised by failure of septation of the outflow tract into aortic and pulmonary trunks and is associated with high morbidity and mortality. Although ranked among the least common congenital heart defects, TA provides an excellent model for the role of individual genes in cardiac morphogenesis as exemplified by TBX1 deficiency caused by point mutations or, more commonly, hemizygosity as part of the 22q11.2 deletion syndrome. The latter genetic lesion, however, is only observed in a proportion of patients with TA, which suggests the presence of additional disease genes. OBJECTIVE: To identify novel genes that cause Mendelian forms of TA. METHODS AND RESULTS: We exploited the occurrence of monogenic forms of TA in the Saudi population, which is characterised by high consanguinity, a feature conducive to the occurrence of Mendelian phenocopies of complex phenotypes as we and others have shown. Indeed, we demonstrate in two multiplex consanguineous families that we are able to map TA to regions of autozygosity in which whole-exome sequencing revealed homozygous truncating mutations in PRKD1 (encoding a kinase derepressor of MAF2) and NRP1 (encoding a coreceptor of vascular endothelial growth factor (VEGFA)). Previous work has demonstrated that Prkd1(-/-) is embryonic lethal and that its tissue-specific deletion results in abnormal heart remodelling, whereas Nrp1(-/-) develops TA. Surprisingly, molecular karyotyping to exclude 22q11.2 deletion syndrome in the replication cohort of 17 simplex TA cases revealed a de novo hemizygous deletion that encompasses PRDM1, deficiency of which also results in TA phenotype in mouse. CONCLUSIONS: Our results expand the repertoire of molecular lesions in chromatin remodelling and transcription factors that are implicated in the pathogenesis of congenital heart disease in humans and attest to the power of monogenic forms of congenital heart diseases as a complementary approach to dissect the genetics of these complex phenotypes. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Ivan Duran; Jessica Tenney; Carmen M Warren; Anna Sarukhanov; Fabiana Csukasi; Mark Skalansky; Maria L Iruela-Arispe; Deborah Krakow Journal: Am J Med Genet A Date: 2018-01-24 Impact factor: 2.802
Authors: Fadi I Musfee; A J Agopian; Elizabeth Goldmuntz; Hakon Hakonarson; Bernice E Morrow; Deanne M Taylor; Martin Tristani-Firouzi; W Scott Watkins; Mark Yandell; Laura E Mitchell Journal: Genes (Basel) Date: 2021-04-27 Impact factor: 4.141
Authors: Alejandro Sifrim; Marc-Phillip Hitz; Anna Wilsdon; Jeroen Breckpot; Saeed H Al Turki; Bernard Thienpont; Jeremy McRae; Tomas W Fitzgerald; Tarjinder Singh; Ganesh Jawahar Swaminathan; Elena Prigmore; Diana Rajan; Hashim Abdul-Khaliq; Siddharth Banka; Ulrike M M Bauer; Jamie Bentham; Felix Berger; Shoumo Bhattacharya; Frances Bu'Lock; Natalie Canham; Irina-Gabriela Colgiu; Catherine Cosgrove; Helen Cox; Ingo Daehnert; Allan Daly; John Danesh; Alan Fryer; Marc Gewillig; Emma Hobson; Kirstin Hoff; Tessa Homfray; Anne-Karin Kahlert; Ami Ketley; Hans-Heiner Kramer; Katherine Lachlan; Anne Katrin Lampe; Jacoba J Louw; Ashok Kumar Manickara; Dorin Manase; Karen P McCarthy; Kay Metcalfe; Carmel Moore; Ruth Newbury-Ecob; Seham Osman Omer; Willem H Ouwehand; Soo-Mi Park; Michael J Parker; Thomas Pickardt; Martin O Pollard; Leema Robert; David J Roberts; Jennifer Sambrook; Kerry Setchfield; Brigitte Stiller; Chris Thornborough; Okan Toka; Hugh Watkins; Denise Williams; Michael Wright; Seema Mital; Piers E F Daubeney; Bernard Keavney; Judith Goodship; Riyadh Mahdi Abu-Sulaiman; Sabine Klaassen; Caroline F Wright; Helen V Firth; Jeffrey C Barrett; Koenraad Devriendt; David R FitzPatrick; J David Brook; Matthew E Hurles Journal: Nat Genet Date: 2016-08-01 Impact factor: 38.330